---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-009747"
form_type: "8-K"
ticker: "GANX"
cik: "0001819411"
company_name: "Gain Therapeutics, Inc."
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:23:06.737579+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Gain Therapeutics posts updated corporate presentation on website

## Summary
- Presentation filed as Exhibit 99.1 on Form 8-K dated February 3, 2026.
- Slides describe business overview; only cover page and disclaimer are in filed text.
- No financial results, pipeline updates, or guidance disclosed in the exhibit.
- Investor presentation routine; no material new information provided.

## SEC filing metadata
- accession: 0001104659-26-009747
- form_type: 8-K
- ticker: GANX
- cik: 0001819411
- company_name: Gain Therapeutics, Inc.
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819411/000110465926009747/0001104659-26-009747-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819411/000110465926009747/tm265021d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-009747
- JSON: https://secwatch.observer/filing/0001104659-26-009747.json
- Plain text: https://secwatch.observer/filing/0001104659-26-009747.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.